Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy
Copyright policy )Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy
The aim of this study was to investigate prognostic value of multidrug resistance protein 1 (MRP1), breast cancer resistance protein (BCRP), lung resistance-related protein (LRP) and excision repair cross-complementing 1 (ERCC1) in patients with locally advanced non-small cell lung cancer (NSCLC) who received neoadjuvant cisplatin-based chemotherapy.Transbronchial biopsy (TBB) specimens from 46 patients with stage IIIA (N(2)) NSCLC were collected to determine the expression level of MRP1, BCRP, LRP and ERCC1 mRNA by semiquantitative RT-PCR. The expression level of each gene was analyzed in relation to histopathologic response to chemotherapy, and tumor-free survival (TFS) and overall survival.Patients with MRP1 or LRP low expression had a significantly better histopathologic response (P=0.032 and 0.006), and a significantly longer TFS (P=0.043 and 0.025) and overall survival (P=0.019 and 0.013) than those with MRP1 or LRP high expression. Patients with ERCC1 low expression had a significantly longer overall survival (P=0.007), but not TFS (P=0.094) than those with ERCC1 high expression. In multivariate analysis, LRP low expression was a significantly favorable factor for TFS (P=0.027), and LRP and ERCC1 were significantly favorable factors for overall survival (P=0.012 and 0.032).Assessment of MRP1 and LRP mRNA expression in TBB specimens may predict histopathologic response and survival in locally advanced NSCLC patients who received neoadjuvant cisplatin-based chemotherapy. ERCC1 expression was predictive for overall survival.
- Affiliated Hospital of Jiangsu University China (People's Republic of)
- Nanjing Medical University China (People's Republic of)
- Jiangsu University China (People's Republic of)
Adult, Male, Lung Neoplasms, Middle Aged, Endonucleases, Prognosis, Disease-Free Survival, Neoadjuvant Therapy, Neoplasm Proteins, DNA-Binding Proteins, Treatment Outcome, Carcinoma, Non-Small-Cell Lung, ATP Binding Cassette Transporter, Subfamily G, Member 2, Humans, ATP-Binding Cassette Transporters, Female, Cisplatin, Multidrug Resistance-Associated Proteins, Aged, Neoplasm Staging
Adult, Male, Lung Neoplasms, Middle Aged, Endonucleases, Prognosis, Disease-Free Survival, Neoadjuvant Therapy, Neoplasm Proteins, DNA-Binding Proteins, Treatment Outcome, Carcinoma, Non-Small-Cell Lung, ATP Binding Cassette Transporter, Subfamily G, Member 2, Humans, ATP-Binding Cassette Transporters, Female, Cisplatin, Multidrug Resistance-Associated Proteins, Aged, Neoplasm Staging
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).59 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!